APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin I2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prostaglandin I2 Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchProstaglandin I2 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin I2 Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Prostaglandin I2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin I2 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin I2 Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Prostaglandin I2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prostaglandin I2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prostaglandin I2 market include Teva, J & J, GSK, Bayer AG, United Therapeutics, Toray and Tide Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prostaglandin I2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostaglandin I2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostaglandin I2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostaglandin I2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostaglandin I2 Segment by Company

Teva

J & J

GSK

Bayer AG

United Therapeutics

Toray

Tide Pharma

Prostaglandin I2 Segment by Type

Epoprostenol Sodium

Iloprost

Treprostinil

Beraprost Sodium

Prostaglandin I2 Segment by Application

For Oral

For Inhalation

For Injection

Prostaglandin I2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prostaglandin I2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Prostaglandin I2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prostaglandin I2 significant trends, drivers, influence factors in global and regions.

6. To analyze Prostaglandin I2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin I2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin I2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin I2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostaglandin I2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostaglandin I2 industry.

Chapter 3: Detailed analysis of Prostaglandin I2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Prostaglandin I2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Prostaglandin I2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prostaglandin I2 Industry Trends Table 2. Prostaglandin I2 Industry Drivers Table 3. Prostaglandin I2 Industry Opportunities and Challenges Table 4. Prostaglandin I2 Industry Restraints Table 5. Global Prostaglandin I2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prostaglandin I2 Revenue Share by Company (2021-2026) Table 7. Global Prostaglandin I2 Sales Volume by Company (k units) & (2021-2026) Table 8. Global Prostaglandin I2 Sales Volume Share by Company (2021-2026) Table 9. Global Prostaglandin I2 Average Price (US$/unit) of Company (2021-2026) Table 10. Global Prostaglandin I2 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Prostaglandin I2 Key Company Manufacturing Base & Headquarters Table 12. Global Prostaglandin I2 Company, Product Type & Application Table 13. Global Prostaglandin I2 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Prostaglandin I2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Epoprostenol Sodium Table 18. Significant Companies of Iloprost Table 19. Significant Companies of Treprostinil Table 20. Significant Companies of Beraprost Sodium Table 21. Global Prostaglandin I2 Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Prostaglandin I2 Sales Volume by Type (2021-2026) & (k units) Table 23. Global Prostaglandin I2 Sales Volume by Type (2027-2032) & (k units) Table 24. Global Prostaglandin I2 Sales Volume Share by Type (2021-2026) Table 25. Global Prostaglandin I2 Sales Volume Share by Type (2027-2032) Table 26. Global Prostaglandin I2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Prostaglandin I2 Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Prostaglandin I2 Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Prostaglandin I2 Sales Value Share by Type (2021-2026) Table 30. Global Prostaglandin I2 Sales Value Share by Type (2027-2032) Table 31. Significant Companies of For Oral Table 32. Significant Companies of For Inhalation Table 33. Significant Companies of For Injection Table 34. Global Prostaglandin I2 Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Prostaglandin I2 Sales Volume by Application (2021-2026) & (k units) Table 36. Global Prostaglandin I2 Sales Volume by Application (2027-2032) & (k units) Table 37. Global Prostaglandin I2 Sales Volume Share by Application (2021-2026) Table 38. Global Prostaglandin I2 Sales Volume Share by Application (2027-2032) Table 39. Global Prostaglandin I2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Prostaglandin I2 Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Prostaglandin I2 Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Prostaglandin I2 Sales Value Share by Application (2021-2026) Table 43. Global Prostaglandin I2 Sales Value Share by Application (2027-2032) Table 44. Global Prostaglandin I2 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Prostaglandin I2 Sales by Region (2021-2026) & (k units) Table 46. Global Prostaglandin I2 Sales Market Share by Region (2021-2026) Table 47. Global Prostaglandin I2 Sales by Region (2027-2032) & (k units) Table 48. Global Prostaglandin I2 Sales Market Share by Region (2027-2032) Table 49. Global Prostaglandin I2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Prostaglandin I2 Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Prostaglandin I2 Sales Value Share by Region (2021-2026) Table 52. Global Prostaglandin I2 Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Prostaglandin I2 Sales Value Share by Region (2027-2032) Table 54. Global Prostaglandin I2 Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Prostaglandin I2 Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Prostaglandin I2 Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Prostaglandin I2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 59. Global Prostaglandin I2 Sales Market Share by Country (2021-2026) Table 60. Global Prostaglandin I2 Sales by Country (2027-2032) & (k units) Table 61. Global Prostaglandin I2 Sales Market Share by Country (2027-2032) Table 62. Global Prostaglandin I2 Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Prostaglandin I2 Sales Value Market Share by Country (2021-2026) Table 64. Global Prostaglandin I2 Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Prostaglandin I2 Sales Value Market Share by Country (2027-2032) Table 66. Teva Company Information Table 67. Teva Business Overview Table 68. Teva Prostaglandin I2 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Teva Prostaglandin I2 Product Portfolio Table 70. Teva Recent Development Table 71. J & J Company Information Table 72. J & J Business Overview Table 73. J & J Prostaglandin I2 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. J & J Prostaglandin I2 Product Portfolio Table 75. J & J Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Prostaglandin I2 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. GSK Prostaglandin I2 Product Portfolio Table 80. GSK Recent Development Table 81. Bayer AG Company Information Table 82. Bayer AG Business Overview Table 83. Bayer AG Prostaglandin I2 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Bayer AG Prostaglandin I2 Product Portfolio Table 85. Bayer AG Recent Development Table 86. United Therapeutics Company Information Table 87. United Therapeutics Business Overview Table 88. United Therapeutics Prostaglandin I2 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. United Therapeutics Prostaglandin I2 Product Portfolio Table 90. United Therapeutics Recent Development Table 91. Toray Company Information Table 92. Toray Business Overview Table 93. Toray Prostaglandin I2 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Toray Prostaglandin I2 Product Portfolio Table 95. Toray Recent Development Table 96. Tide Pharma Company Information Table 97. Tide Pharma Business Overview Table 98. Tide Pharma Prostaglandin I2 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Tide Pharma Prostaglandin I2 Product Portfolio Table 100. Tide Pharma Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Prostaglandin I2 Distributors List Table 104. Prostaglandin I2 Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Prostaglandin I2 Product Image Figure 2. Global Prostaglandin I2 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin I2 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Prostaglandin I2 Sales (2021-2032) & (k units) Figure 5. Global Prostaglandin I2 Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Prostaglandin I2 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Epoprostenol Sodium Image Figure 10. Iloprost Image Figure 11. Treprostinil Image Figure 12. Beraprost Sodium Image Figure 13. Global Prostaglandin I2 Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Prostaglandin I2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Prostaglandin I2 Sales Volume Share by Type (2021-2032) Figure 16. Global Prostaglandin I2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Prostaglandin I2 Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Prostaglandin I2 Sales Value Share by Type (2021-2032) Figure 19. For Oral Image Figure 20. For Inhalation Image Figure 21. For Injection Image Figure 22. Global Prostaglandin I2 Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Prostaglandin I2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Prostaglandin I2 Sales Volume Share by Application (2021-2032) Figure 25. Global Prostaglandin I2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Prostaglandin I2 Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Prostaglandin I2 Sales Value Share by Application (2021-2032) Figure 28. Global Prostaglandin I2 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Prostaglandin I2 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Prostaglandin I2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Prostaglandin I2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Prostaglandin I2 Sales Value (2021-2032) & (US$ Million) Figure 33. North America Prostaglandin I2 Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Prostaglandin I2 Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Prostaglandin I2 Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Prostaglandin I2 Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Prostaglandin I2 Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Prostaglandin I2 Sales Value (2021-2032) & (US$ Million) Figure 39. South America Prostaglandin I2 Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Prostaglandin I2 Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Prostaglandin I2 Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Prostaglandin I2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Prostaglandin I2 Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Prostaglandin I2 Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Epoprostenol Sodium
  • Iloprost
  • Treprostinil
  • Beraprost Sodium
Applications
  • For Oral
  • For Inhalation
  • For Injection
Companies covered
  • Teva
  • J & J
  • GSK
  • Bayer AG
  • United Therapeutics
  • Toray
  • Tide Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostaglandin I2 Sales Value (2021-2032)
  4. 1.2.2 Global Prostaglandin I2 Sales Volume (2021-2032)
  5. 1.2.3 Global Prostaglandin I2 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Prostaglandin I2 Market Dynamics
  1. 2.1 Prostaglandin I2 Industry Trends
  2. 2.2 Prostaglandin I2 Industry Drivers
  3. 2.3 Prostaglandin I2 Industry Opportunities and Challenges
  4. 2.4 Prostaglandin I2 Industry Restraints
3 Prostaglandin I2 Market by Company
  1. 3.1 Global Prostaglandin I2 Company Revenue Ranking in 2025
  2. 3.2 Global Prostaglandin I2 Revenue by Company (2021-2026)
  3. 3.3 Global Prostaglandin I2 Sales Volume by Company (2021-2026)
  4. 3.4 Global Prostaglandin I2 Average Price by Company (2021-2026)
  5. 3.5 Global Prostaglandin I2 Company Ranking (2024-2026)
  6. 3.6 Global Prostaglandin I2 Company Manufacturing Base and Headquarters
  7. 3.7 Global Prostaglandin I2 Company Product Type and Application
  8. 3.8 Global Prostaglandin I2 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Prostaglandin I2 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Prostaglandin I2 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Prostaglandin I2 Market by Type
  1. 4.1 Prostaglandin I2 Type Introduction
  2. 4.1.1 Epoprostenol Sodium
  3. 4.1.2 Iloprost
  4. 4.1.3 Treprostinil
  5. 4.1.4 Beraprost Sodium
  6. 4.2 Global Prostaglandin I2 Sales Volume by Type
  7. 4.2.1 Global Prostaglandin I2 Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Prostaglandin I2 Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Prostaglandin I2 Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Prostaglandin I2 Sales Value by Type
  11. 4.3.1 Global Prostaglandin I2 Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Prostaglandin I2 Sales Value by Type (2021-2032)
  13. 4.3.3 Global Prostaglandin I2 Sales Value Share by Type (2021-2032)
5 Prostaglandin I2 Market by Application
  1. 5.1 Prostaglandin I2 Application Introduction
  2. 5.1.1 For Oral
  3. 5.1.2 For Inhalation
  4. 5.1.3 For Injection
  5. 5.2 Global Prostaglandin I2 Sales Volume by Application
  6. 5.2.1 Global Prostaglandin I2 Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostaglandin I2 Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Prostaglandin I2 Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Prostaglandin I2 Sales Value by Application
  10. 5.3.1 Global Prostaglandin I2 Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prostaglandin I2 Sales Value by Application (2021-2032)
  12. 5.3.3 Global Prostaglandin I2 Sales Value Share by Application (2021-2032)
6 Prostaglandin I2 Regional Sales and Value Analysis
  1. 6.1 Global Prostaglandin I2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostaglandin I2 Sales by Region (2021-2032)
  3. 6.2.1 Global Prostaglandin I2 Sales by Region: 2021-2026
  4. 6.2.2 Global Prostaglandin I2 Sales by Region (2027-2032)
  5. 6.3 Global Prostaglandin I2 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Prostaglandin I2 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Prostaglandin I2 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Prostaglandin I2 Sales Value by Region (2027-2032)
  9. 6.5 Global Prostaglandin I2 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Prostaglandin I2 Sales Value (2021-2032)
  12. 6.6.2 North America Prostaglandin I2 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Prostaglandin I2 Sales Value (2021-2032)
  15. 6.7.2 Europe Prostaglandin I2 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Prostaglandin I2 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Prostaglandin I2 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Prostaglandin I2 Sales Value (2021-2032)
  21. 6.9.2 South America Prostaglandin I2 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Prostaglandin I2 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Prostaglandin I2 Sales Value Share by Country, 2025 VS 2032
7 Prostaglandin I2 Country-level Sales and Value Analysis
  1. 7.1 Global Prostaglandin I2 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prostaglandin I2 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Prostaglandin I2 Sales by Country (2021-2032)
  4. 7.3.1 Global Prostaglandin I2 Sales by Country (2021-2026)
  5. 7.3.2 Global Prostaglandin I2 Sales by Country (2027-2032)
  6. 7.4 Global Prostaglandin I2 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Prostaglandin I2 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Prostaglandin I2 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Prostaglandin I2 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Prostaglandin I2 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Prostaglandin I2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Prostaglandin I2 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Prostaglandin I2 Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 J & J
  8. 8.2.1 J & J Company Information
  9. 8.2.2 J & J Business Overview
  10. 8.2.3 J & J Prostaglandin I2 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 J & J Prostaglandin I2 Product Portfolio
  12. 8.2.5 J & J Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Prostaglandin I2 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GSK Prostaglandin I2 Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Bayer AG
  20. 8.4.1 Bayer AG Company Information
  21. 8.4.2 Bayer AG Business Overview
  22. 8.4.3 Bayer AG Prostaglandin I2 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer AG Prostaglandin I2 Product Portfolio
  24. 8.4.5 Bayer AG Recent Developments
  25. 8.5 United Therapeutics
  26. 8.5.1 United Therapeutics Company Information
  27. 8.5.2 United Therapeutics Business Overview
  28. 8.5.3 United Therapeutics Prostaglandin I2 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 United Therapeutics Prostaglandin I2 Product Portfolio
  30. 8.5.5 United Therapeutics Recent Developments
  31. 8.6 Toray
  32. 8.6.1 Toray Company Information
  33. 8.6.2 Toray Business Overview
  34. 8.6.3 Toray Prostaglandin I2 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Toray Prostaglandin I2 Product Portfolio
  36. 8.6.5 Toray Recent Developments
  37. 8.7 Tide Pharma
  38. 8.7.1 Tide Pharma Company Information
  39. 8.7.2 Tide Pharma Business Overview
  40. 8.7.3 Tide Pharma Prostaglandin I2 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Tide Pharma Prostaglandin I2 Product Portfolio
  42. 8.7.5 Tide Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prostaglandin I2 Value Chain Analysis
  2. 9.1.1 Prostaglandin I2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prostaglandin I2 Sales Mode & Process
  6. 9.2 Prostaglandin I2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prostaglandin I2 Distributors
  9. 9.2.3 Prostaglandin I2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst